logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11813233 B1

PDFFull Text
Date of Patent:
Nov. 14, 2023

Filed:

Sep. 29, 2017

Omega 3 fatty acids and choline as neuroprotectant in patients with no dementia

Applicant:

Nestec S.a., Vevey, CH;

Inventors:

Claus Rieker, St-Sulpice, CH;

Julie Hudry-Labbe, Epalinges, CH;

Jeroen Antonius Johannes Schmitt, Moudon, CH;

Corina Boschat, Lausanne, CH;

Yvonne Beata Silber, Essertes, CH;

Assignee:

Societe des Produits Nestle S.A., Vevey, CH;

Attorney:

K&L Gates LLP

Primary Examiner:

Craig D Ricci

Assistant Examiner:

Janet L Coppins

Int. Cl.
CPC ...
A61K 31/202 (2006.01); A61K 31/197 (2006.01); A61K 31/519 (2006.01); A61K 31/14 (2006.01); A61K 31/714 (2006.01); A61K 31/198 (2006.01); A61K 31/4415 (2006.01); A61K 31/17 (2006.01); A61K 31/375 (2006.01); A61K 31/4406 (2006.01); A61K 33/00 (2006.01); A61K 31/341 (2006.01); A61K 31/355 (2006.01); A61K 31/4188 (2006.01); A61K 31/455 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/59 (2006.01); A61K 31/675 (2006.01); A61K 33/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/714 (2013.01); A61K 31/14 (2013.01); A61K 31/17 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/202 (2013.01); A61K 31/341 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4188 (2013.01); A61K 31/4406 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/59 (2013.01); A61K 31/675 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01);
Abstract

A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid and choline. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-β phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human. The composition can be administered to the individual in a daily dose that provides 5.5 mg/day to 5,500 mg/day of the choline, for example 85 mg/day to 3,500 mg/day of the choline.

Find Patent Forward Citations

Loading…